| Dr Rachel Marie Archer, AUD | |
|
2621 Ne 134th St Ste 300, Vancouver, WA 98686-3036 | |
| (360) 882-2778 | |
| Not Available |
| Full Name | Dr Rachel Marie Archer |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 3 Years |
| Location | 2621 Ne 134th St Ste 300, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558036897 | NPI | - | NPPES |
| 14415484 | Other | ASHA CERTIFICATE OF CLINICAL COMPETENCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 110126 (Iowa) | Secondary |
| 231H00000X | Audiologist | LD61459782 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Vancouver Clinic Inc Ps | 3173436490 | 471 |
News Archive
A ban on the use of a mercury-based preservative in vaccines tabled by the United Nations Environmental Program should be struck from a draft treaty as it may severely affect access to vaccines, experts urge.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
A team of Russian researchers with the participation of a leading researcher at HSE University, Ekaterina Pechenkova, found that during group problem solving the components of the social brain are co-activated, but they do not increase their coupling during cooperation as would be suggested for a holistic network.
A George Washington University professor has designed new technology that can identify traces of chemicals at 10-19 moles, a previously undetectable amount. This minute quantity can be conceptualized as 10 times below a billionth of a billionth of a teaspoon of water.
Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.
› Verified 3 days ago
| Provider Name | The Vancouver Clinic Inc Ps |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992759427 PECOS PAC ID: 3173436490 Enrollment ID: O20031111000793 |
News Archive
A ban on the use of a mercury-based preservative in vaccines tabled by the United Nations Environmental Program should be struck from a draft treaty as it may severely affect access to vaccines, experts urge.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
A team of Russian researchers with the participation of a leading researcher at HSE University, Ekaterina Pechenkova, found that during group problem solving the components of the social brain are co-activated, but they do not increase their coupling during cooperation as would be suggested for a holistic network.
A George Washington University professor has designed new technology that can identify traces of chemicals at 10-19 moles, a previously undetectable amount. This minute quantity can be conceptualized as 10 times below a billionth of a billionth of a teaspoon of water.
Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel Marie Archer, AUD Po Box 4825, Portland, OR 97208-4825 Ph: () - | Dr Rachel Marie Archer, AUD 2621 Ne 134th St Ste 300, Vancouver, WA 98686-3036 Ph: (360) 882-2778 |
News Archive
A ban on the use of a mercury-based preservative in vaccines tabled by the United Nations Environmental Program should be struck from a draft treaty as it may severely affect access to vaccines, experts urge.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
A team of Russian researchers with the participation of a leading researcher at HSE University, Ekaterina Pechenkova, found that during group problem solving the components of the social brain are co-activated, but they do not increase their coupling during cooperation as would be suggested for a holistic network.
A George Washington University professor has designed new technology that can identify traces of chemicals at 10-19 moles, a previously undetectable amount. This minute quantity can be conceptualized as 10 times below a billionth of a billionth of a teaspoon of water.
Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.
› Verified 3 days ago
Mr. Alamander Hicks, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Suite 150, Vancouver, WA 98664 Phone: 360-892-9367 Fax: 360-253-3801 | |
Dr. Kalani Jane Cox, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 611 Grand Blvd, Vancouver, WA 98661 Phone: 360-418-4350 Fax: 360-418-4298 | |
Dr. Christopher Kyle Cox, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 11201 Ne 9th St, Ste 300, Vancouver, WA 98684 Phone: 971-333-1179 | |
Audiology Clinic, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 505 Ne 87th Ave, Suite 150, Vancouver, WA 98664 Phone: 360-892-9367 Fax: 360-253-3801 | |
Luna Family Hearing Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11516 Se Mill Plain Blvd, Suite J-2, Vancouver, WA 98684 Phone: 360-882-8027 Fax: 360-882-8030 | |
Hearing Center Of Vancouver Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 16320 Se Mill Plain Blvd Ste 103, Vancouver, WA 98684 Phone: 360-816-2958 | |
Dr. Sara Michelle Bodack, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2525 Ne 139th St Ste 230, Vancouver, WA 98686 Phone: 360-882-2778 Fax: 360-604-1673 |